ATE188704T1 - Phosphonsäurediester-derivat - Google Patents

Phosphonsäurediester-derivat

Info

Publication number
ATE188704T1
ATE188704T1 AT93910361T AT93910361T ATE188704T1 AT E188704 T1 ATE188704 T1 AT E188704T1 AT 93910361 T AT93910361 T AT 93910361T AT 93910361 T AT93910361 T AT 93910361T AT E188704 T1 ATE188704 T1 AT E188704T1
Authority
AT
Austria
Prior art keywords
diester derivative
phosphonic acid
acid diester
derivative
hyperlipidemia
Prior art date
Application number
AT93910361T
Other languages
English (en)
Inventor
Kazuyoshi Miyata
Yasuo Shoji
Yoshihiko Tsuda
Kazuhiko Tsutsumi
Yasuhide Inoue
Chieko Naba
Yasuhisa Kurogi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE188704T1 publication Critical patent/ATE188704T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • C07F9/65324Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93910361T 1992-05-21 1993-05-20 Phosphonsäurediester-derivat ATE188704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12871192 1992-05-21
PCT/JP1993/000660 WO1993023409A1 (fr) 1992-05-21 1993-05-20 Derive de diester phosphonique

Publications (1)

Publication Number Publication Date
ATE188704T1 true ATE188704T1 (de) 2000-01-15

Family

ID=14991544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93910361T ATE188704T1 (de) 1992-05-21 1993-05-20 Phosphonsäurediester-derivat

Country Status (13)

Country Link
US (1) US5376665A (de)
EP (1) EP0604657B1 (de)
JP (1) JP2759228B2 (de)
KR (1) KR0185225B1 (de)
AT (1) ATE188704T1 (de)
AU (1) AU653681B2 (de)
CA (1) CA2113561C (de)
DE (1) DE69327572T2 (de)
DK (1) DK0604657T3 (de)
ES (1) ES2140456T3 (de)
PT (1) PT604657E (de)
TW (1) TW243451B (de)
WO (1) WO1993023409A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW260664B (de) * 1993-02-15 1995-10-21 Otsuka Pharma Factory Inc
JP3156026B2 (ja) 1993-12-27 2001-04-16 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
JP3533542B2 (ja) * 1994-03-08 2004-05-31 株式会社大塚製薬工場 ホスホン酸ジエステル誘導体
US5442118A (en) * 1994-04-22 1995-08-15 Sepracor, Inc. Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones
US6288100B1 (en) 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
DE69624143T2 (de) * 1995-12-27 2003-06-12 Otsuka Pharmaceutical Factory, Inc. Phosphonsaurediester-derivate
CA2259431A1 (en) * 1996-07-01 1998-01-08 Eli Lilly And Company Hypoglycemic and hypolipidemic compounds
CA2259487A1 (en) 1996-07-01 1998-01-08 Margaret Mary Faul Hypoglycemic and hypolipidemic compounds
EP1402895A1 (de) * 1997-03-07 2004-03-31 Metabasis Therapeutics, Inc. Benzimidazolinhibitoren der Fructose 1,6-biphosphatase
US6284748B1 (en) 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
DE69819311T2 (de) 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
PL337888A1 (en) 1997-07-03 2000-09-11 Du Pont Pharm Co Imidazoprimidines and imidazopyridines for use in treating neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
AU2001281817B2 (en) * 2000-06-21 2005-11-24 F. Hoffmann-La Roche Ag Benzothiazole derivatives
US20040029867A1 (en) * 2001-05-04 2004-02-12 Scarborough Robert M. Heterobicyclic sulfonamides and their use as platelet adp receptor inhibitors
US7132438B2 (en) 2001-10-09 2006-11-07 Amgen Inc. Benzimidazole derivatives
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
RU2344132C2 (ru) * 2003-06-20 2009-01-20 Ф.Хоффманн-Ля Рош Аг 2-аминобензотиазолы в качестве обратных агонистов рецепторов cb1
EP1680431A1 (de) * 2003-10-17 2006-07-19 Rigel Pharmaceuticals, Inc. Benzothiazol- und thiazol[5,5-b]pyridinzusammensetzungen und deren verwendung als ubiquitinligaseinhibitoren
RS50574B (sr) 2004-05-24 2010-05-07 F. Hoffmann-La Roche Ag. (4-metoksi-7-morfolin-4-il-benzotiazol-2-il)-amid 4-hidroksi-4-metil-piperidin-1-karboksilne kiseline
ES2309814T3 (es) 2004-11-05 2008-12-16 F. Hoffmann-La Roche Ag Proceso para la obtencion de derivados del acido isonicotinico.
WO2006099972A1 (en) 2005-03-23 2006-09-28 F. Hoffmann-La Roche Ag Acetylenyl-pyrazolo-pvrimidine derivatives as mglur2 antagonists
JP5048675B2 (ja) 2005-09-27 2012-10-17 エフ.ホフマン−ラ ロシュ アーゲー mGluR2アンタゴニストとしてのオキサジアゾリルピラゾロ−ピリミジン類
DE102007012284A1 (de) 2007-03-16 2008-09-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035334A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007042154A1 (de) 2007-09-05 2009-03-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arylsulfonylaminomethyphosphonsäure-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
EP2348857B1 (de) * 2008-10-22 2016-02-24 Merck Sharp & Dohme Corp. Neue cyclische benzimidazolderivate als antidiabetika
SG10201505997TA (en) 2010-08-05 2015-09-29 Amgen Inc Benzimidazole And Azabenzimidazole Compounds That Inhibit Anaplastic Lymphoma Kinase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU523040B2 (en) * 1978-05-15 1982-07-08 Kanebo Limited Calcium -antagonistic composition
NZ234564A (en) * 1986-11-21 1991-04-26 Haessle Ab 1-substituted benzimidazoles and pharmaceutical compositions

Also Published As

Publication number Publication date
DE69327572T2 (de) 2000-06-21
EP0604657B1 (de) 2000-01-12
JP2759228B2 (ja) 1998-05-28
WO1993023409A1 (fr) 1993-11-25
TW243451B (de) 1995-03-21
DE69327572D1 (de) 2000-02-17
AU653681B2 (en) 1994-10-06
CA2113561C (en) 1999-09-14
AU4088793A (en) 1993-12-13
US5376665A (en) 1994-12-27
EP0604657A1 (de) 1994-07-06
PT604657E (pt) 2000-04-28
EP0604657A4 (de) 1995-03-15
CA2113561A1 (en) 1993-11-25
DK0604657T3 (da) 2000-04-17
KR0185225B1 (ko) 1999-05-15
ES2140456T3 (es) 2000-03-01

Similar Documents

Publication Publication Date Title
DE69327572D1 (de) Phosphonsäurediester-derivat
AU696851B2 (en) Method of treating hyperproliferative vascular disease
NO976085D0 (no) Difenylmetylen-piperidin-derivater
FI92695B (fi) Uusi menetelmä heksa-, okta- tai dekahydronaftyylietyylisubstituoitujen 4-hydroksitetrahydropyran-2-onijohdannaisten valmistamiseksi
ZA911502B (en) A pharmaceutical solution
ATE172957T1 (de) Fluoroalkenyl verbindungen und ihre verwendung als schädlingsbekämpfungsmittel
ATE93838T1 (de) Triphenylmethan-derivate.
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
ATE117989T1 (de) Prostaglandinanaloge enthaltende lipidemulsion.
DE69615158D1 (de) Phenylbenzoesäureester-derivate und flüssigkristallzubereitungen
ES2106058T3 (es) Derivados de benzamida.
FI893682A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi
ES2054007T3 (es) Compuesto de quinolina.
SE8704542D0 (sv) New derivatives of cysteine
DK0541322T3 (da) 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet
ATE146481T1 (de) Epoxysuccinamidsäurederivat
DE69215588D1 (de) Inositol-Phosphat-Analog als kalzium-antagonistische Substanz
DE69108580D1 (de) Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen.
ATE146472T1 (de) Umwandlungsverfahren von lorabef dihydrate in loracarbef monohydrate
ZA899821B (en) Novel compounds
ATE159253T1 (de) 2-thiazolylpyrroleakrylate mit fungizider wirkung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee